Vanda Pharmaceuticals (VNDA) Q2 2024 Earnings

May 8Confirmed
Q2 2023
Q3 2023
Q4 2023
Q2 2024
-0.13
-0.07
-0.01
0.05

Details

Expected EPS
0.05
Actual EPS
-0.07
Surprise EPS
-0.12
Surprise Percent
-240%

Description

⁨Vanda Pharmaceuticals⁩ (⁦VNDA⁩) has reported earnings of ⁦-0.07⁩ per share for ⁦Q2 2024⁩.

0 Comments

Share your thoughts